Gleevec

Novartis, Sun Pharma Gleevec patent battle moves to U.S.

Novartis, Sun Pharma Gleevec patent battle moves to U.S.

Fierce Pharma

Ariad's Cancer Drug Iclusig Extends The Gleevec Magic

Ariad's Cancer Drug Iclusig Extends The Gleevec Magic

Seeking Alpha

Tackling Cancer: Leukemia's Biggest Current and Upcoming Players

Tackling Cancer: Leukemia's Biggest Current and Upcoming Players

Motley Fool

Doctors blast ethics of $100,000 cancer drugs

Doctors blast ethics of $100,000 cancer drugs

CNN Money

Novartis loses landmark India patent case on Glivec

Novartis loses landmark India patent case on Glivec

Reuters

Novartis Cannibalizes Gleevec to Boost New Cancer Drug

Novartis Cannibalizes Gleevec to Boost New Cancer Drug

Bloomberg

Supreme Court to hear Novartis patent case from Sept 11

Supreme Court to hear Novartis patent case from Sept 11

Reuters

Novartis, A Gleevec Patent & India: Herrling Explains

Novartis, A Gleevec Patent & India: Herrling Explains

Pharmalot

Kedem Pharma begins development of anti-cancer drug, Gleevec

Kedem Pharma begins development of anti-cancer drug, Gleevec

Pharmabiz

Novartis fights patent rejection in Indian court

Novartis fights patent rejection in Indian court

Yahoo/AP